StockNews.com Initiates Coverage on vTv Therapeutics (NASDAQ:VTVT)

StockNews.com started coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a report published on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. vTv Therapeutics Trading Up 0.5 % VTVT stock opened at $10.54 on Friday. vTv Therapeutics has a 12 month low of $9.10 and a 12 month […]

Leave a Reply

Your email address will not be published.

Previous post Run it back: Hoffmeister family part of Needham tradition
Next post Mexco Energy (NYSE:MXC) Now Covered by StockNews.com